Literature DB >> 9633720

Migraine and reduced work performance: a population-based diary study.

M Von Korff1, W F Stewart, D J Simon, R B Lipton.   

Abstract

OBJECTIVE: This article estimates lost work days and lost work day equivalents in a population sample of migraineurs, differentiating work loss due to headache episodes that met criteria for migraine from migrainous headaches not meeting full criteria and nonmigrainous headaches.
METHODS: A random digit dialing survey of 5,071 adults identified 800 subjects with migraine headaches. By clinical examination, a subsample of 225 met migraine diagnostic criteria; 174 of these patients completed at least 11 weeks of daily diaries. This report concerns the subgroup of 122 individuals with regular paid employment. Subjects completed a daily diary over a 3-month period to assess the occurrence of headaches and International Headache Society (IHS) criteria for each headache occurrence. We report estimates of lost work days and lost work day equivalents by type of headache.
RESULTS: Participants reported headaches on 8.1 work days, of which 2.2 headache days met criteria for migraine (IHS 1.1, 1.2), and an additional 2.1 headache days were migrainous without meeting full migraine criteria (IHS 1.7). On average, migraineurs missed 1.1 days of work due to headache in 3 months, of which 0.7 lost work days were due to migraine and 0.3 were due to migrainous headaches. When at work with headache, work effectiveness was reduced 41% for migraine headaches, 28% for migrainous headaches, and 24% for other headaches. Over 3 months, migraineurs experienced an average of 3.0 lost work day equivalents, of which 1.4 were due to migraine and an additional 0.7 were due to migrainous headaches. The most disabled 20% of the participants accounted for 77% of the lost work days; 40% of subjects accounted for 75% of the lost work day equivalents.
CONCLUSIONS: Employed migraine sufferers experienced considerable work loss and reduced work performance due to headache. The most severely affected migraineurs accounted for most of the reduced work performance. Targeting the most severely affected persons may be necessary to reduce work loss among migraineurs substantially.

Entities:  

Mesh:

Year:  1998        PMID: 9633720     DOI: 10.1212/wnl.50.6.1741

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Breakout session: Gender and ethnic disparities in pain management.

Authors:  Atul F Kamath; Mary I O'Connor
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

Review 2.  Chronic daily headache.

Authors:  Peter J Goadsby; Christopher Boes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 3.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

4.  Natural history of upper extremity musculoskeletal symptoms and resulting work limitations over 3 years in a newly hired working population.

Authors:  Bethany T Gardner; Ann Marie Dale; Alexis Descatha; Bradley Evanoff
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

Review 5.  Workplace productivity. A review of the impact of migraine and its treatment.

Authors:  P Stang; R Cady; A Batenhorst; L Hoffman
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

6.  The migraine work and productivity loss questionnaire: concepts and design.

Authors:  D J Lerner; B C Amick; S Malspeis; W H Rogers; N C Santanello; W C Gerth; R B Lipton
Journal:  Qual Life Res       Date:  1999-12       Impact factor: 4.147

7.  Exposure to Psychological Aggression at Work and Job Performance: The Mediating Role of Job Attitudes and Personal Health.

Authors:  Aaron Schat; Michael R Frone
Journal:  Work Stress       Date:  2011-01-01

8.  Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation.

Authors:  Gregg A Tkachuk; Constance K Cottrell; Jessica S Gibson; Francis J O'Donnell; Kenneth A Holroyd
Journal:  Headache       Date:  2003-10       Impact factor: 5.887

9.  Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.

Authors:  Stephen Landy; Sarah E DeRossett; Alan Rapoport; John Rothrock; Michael H Ames; Susan A McDonald; Steven P Burch
Journal:  MedGenMed       Date:  2007-06-07

10.  Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Authors:  Kenneth A Holroyd; Constance K Cottrell; Francis J O'Donnell; Gary E Cordingley; Jana B Drew; Bruce W Carlson; Lina Himawan
Journal:  BMJ       Date:  2010-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.